Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply

Detalles Bibliográficos
Autores principales: Crescioli, Giada, Lanzi, Cecilia, Mannaioni, Guido, Vannacci, Alfredo, Lombardi, Niccolò
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Ce-Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908935/
https://www.ncbi.nlm.nih.gov/pubmed/33635496
http://dx.doi.org/10.1007/s11739-021-02677-0
_version_ 1783655820124225536
author Crescioli, Giada
Lanzi, Cecilia
Mannaioni, Guido
Vannacci, Alfredo
Lombardi, Niccolò
author_facet Crescioli, Giada
Lanzi, Cecilia
Mannaioni, Guido
Vannacci, Alfredo
Lombardi, Niccolò
author_sort Crescioli, Giada
collection PubMed
description
format Online
Article
Text
id pubmed-7908935
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-79089352021-02-26 Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply Crescioli, Giada Lanzi, Cecilia Mannaioni, Guido Vannacci, Alfredo Lombardi, Niccolò Intern Emerg Med Ce-Letter to the Editor Springer International Publishing 2021-02-26 2021 /pmc/articles/PMC7908935/ /pubmed/33635496 http://dx.doi.org/10.1007/s11739-021-02677-0 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Ce-Letter to the Editor
Crescioli, Giada
Lanzi, Cecilia
Mannaioni, Guido
Vannacci, Alfredo
Lombardi, Niccolò
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title_full Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title_fullStr Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title_full_unstemmed Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title_short Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
title_sort adverse drug reactions in sars-cov-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
topic Ce-Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908935/
https://www.ncbi.nlm.nih.gov/pubmed/33635496
http://dx.doi.org/10.1007/s11739-021-02677-0
work_keys_str_mv AT crescioligiada adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionsreply
AT lanzicecilia adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionsreply
AT mannaioniguido adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionsreply
AT vannaccialfredo adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionsreply
AT lombardiniccolo adversedrugreactionsinsarscov2hospitalisedpatientsacaseserieswithafocusondrugdruginteractionsreply

Ejemplares similares